Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EchinoVISTA: Albendazole in Alveolar Echinococcosis
NCT02876146Completed
- Sponsor
- CHU de Besançon
- Start
- Jun 2012
- Primary completion
- Aug 2021
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of albendazole in Alveolar echinococcosis (AE), sponsored by CHU de Besançon. Primary endpoint: Ratio of non-operated on patients with negative viability markers after a 4 years benzimidazole treatment. Started Jun 2012; status: completed.
02
Drugs
albendazole
03
Conditions
Alveolar echinococcosis (AE)
Beyond the preview
Go deeper on NCT02876146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02876146.